CureVac

CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena
Thu, 04/25/24 - 11:35 am
CureVac
GSK
vaccines
H5N1
clinical trials
CureVac to cut costs in restructuring
BioPharma Dive
Wed, 04/24/24 - 09:14 pm
CureVac
vaccines
layoffs
CureVac, chasing Moderna's mRNA flu vaccine, runs into the same B strain problems
Fierce Biotech
Thu, 04/4/24 - 11:24 am
CureVac
Moderna Therapeutics
MRNA
flu vaccine
Flu
influenza B
vaccines
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
Fierce Pharma
Thu, 09/28/23 - 11:40 pm
CureVac
BioNTech
MRNA
patents
legal
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
Medical Marketing and Media
Fri, 05/19/23 - 10:22 am
CureVac
COVID-19
vaccines
Pfizer
BioNTech
patents legal
Orbital shows 2023’s venture funding scene is far from stratospheric
EP Vantage
Fri, 05/19/23 - 10:06 am
RNA
funding
venture capital
Altos Labs
CureVac
EQRx
Hasten Biopharmaceutic
Orbital Therapeutics
Sana Biotechnology
Suzhou Abogen Biosciences
TORL BioTherapeutics
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
Mon, 05/8/23 - 11:27 pm
GSK
CureVac
vaccines
MRNA
Flu
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
Fierce Biotech
Mon, 01/30/23 - 10:33 am
CureVac
clinical trials
MRNA
vaccines
COVID-19
Flu
GSK
CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%
Fierce Biotech
Sun, 01/8/23 - 10:05 pm
CureVac
GSK
MRNA
vaccines
COVID-19
clinical trials
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
CureVac
vaccines
CV8102
MRNA
cancer
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial
Clinical Trials Arena
Fri, 08/19/22 - 10:31 am
CureVac
clinical trials
MRNA
CV0501
boosters
COVID-19
Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
BioSpace
Wed, 07/27/22 - 10:47 am
Pfizer
BioNTech
COVID-19
vaccines
boosters
patents
CureVac
Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty
Fierce Pharma
Tue, 07/26/22 - 11:23 am
Pfizer
BioNTech
COVID-19
CureVac
vaccines
patents
After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement
Fierce Pharma
Tue, 07/5/22 - 10:46 am
COVID-19
CureVac
BioNTech
patents
vaccines
CureVac increases focus on cancer vaccine development
Biopharma Reporter
Mon, 05/30/22 - 10:17 am
CureVac
myNEO
vaccines
cancer
MRNA
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech
Fierce Biotech
Wed, 05/25/22 - 11:32 pm
CureVac
COVID-19
vaccines
earnings
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts
Fierce Pharma
Mon, 04/11/22 - 10:33 am
GSK
BioNTech
CureVac
Germany
pandemic
CureVac and GSK try again with COVID-19 vaccine
Pharmaforum
Thu, 03/31/22 - 10:21 am
GSK
CureVac
vaccines
COVID-19
MRNA

Pages